Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Pinsky

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2019
Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39Anuli C Anyanwu, Yogendra Kanthi, Keigo Fukase, et al.
Nature Communications|April 25, 2019
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndromeRamadan A Ali, Alex A Gandhi, He Meng, et al.
The Journal of Clinical Investigation|April 17, 2019
Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosisVinita Yadav, Liguo Chi, Raymond Zhao, et al.
JCI Insight|January 19, 2017
Ectonucleotidase CD39-driven control of postinfarction myocardial repair and ruptureNadia R Sutton, Takanori Hayasaki, Matthew C Hyman, et al.
The Journal of Clinical Investigation|April 17, 2002
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainDavid J Pinsky, M Johan Broekman, Jacques J Peschon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2004
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary diseaseWen Ning, Chao-Jun Li, Naftali Kaminski, et al.
The Journal of Clinical Investigation|October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2019
Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39Anuli C Anyanwu, Yogendra Kanthi, Keigo Fukase, et al.
Nature Communications|April 25, 2019
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndromeRamadan A Ali, Alex A Gandhi, He Meng, et al.
The Journal of Clinical Investigation|April 17, 2019
Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosisVinita Yadav, Liguo Chi, Raymond Zhao, et al.
JCI Insight|January 19, 2017
Ectonucleotidase CD39-driven control of postinfarction myocardial repair and ruptureNadia R Sutton, Takanori Hayasaki, Matthew C Hyman, et al.
The Journal of Clinical Investigation|April 17, 2002
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainDavid J Pinsky, M Johan Broekman, Jacques J Peschon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2004
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary diseaseWen Ning, Chao-Jun Li, Naftali Kaminski, et al.
The Journal of Clinical Investigation|October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
Pageof 10